Skip to main navigation Skip to search Skip to main content

KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: A report from the Children's Oncology Group

  • Amy K. Erbe*
  • , Mitch B. Diccianni
  • , Rajen Mody
  • , Arlene Naranjo
  • , Fan F. Zhang
  • , Jen Birstler
  • , Kyungmann Kim
  • , Arika S. Feils
  • , Jung Tung Hung
  • , Wendy B. London
  • , Barry L. Shulkin
  • , Varsha Mathew
  • , Marguerite T. Parisi
  • , Sabah Servaes
  • , Shahab Asgharzadeh
  • , John M. Maris
  • , Julie Park
  • , Alice L. Yu
  • , Paul M. Sondel
  • , Rochelle Bagatell
    • *Corresponding author for this work
  • University of Wisconsin-Madison
  • University of California at San Diego
  • University of Michigan, Ann Arbor
  • University of Florida
  • CureSearch
  • Chang Gung Memorial Hospital
  • Dana-Farber Cancer Institute
  • St. Jude Children Research Hospital
  • Seattle Children's Hospital
  • The Children's Hospital of Philadelphia
  • Children's Hospital Los Angeles

Research output: Contribution to journal › Journal Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: A report from the Children's Oncology Group'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology